PNS133 BEYOND INTERNATIONAL PRICING INDEX MODEL IN THE UNITED STATES - IMPACT TO GLOBAL PRICING STRATEGIES & ACCESS TO INNOVATIVE MEDICINES

Access to innovative oncology medicines in Europe

This article intends to give an overview about developments in European Regulatory and Health Technology Assessment (HTA) of new cancer drugs. As background information, it will refer to an overview article by Bergmann et al. [1], which pointed out the status and the limitations of the current system. The authors discussed possible steps to improve the interface between regulators and HTA bodie...

Pricing hospital care: Global budgets and marginal pricing strategies.

OBJECTIVE The Canadian province of British Columbia (BC) is adding financial incentives to increase the volume of surgeries provided by hospitals using a marginal pricing approach. The objective of this study is to calculate marginal costs of surgeries based on assumptions regarding hospitals' availability of labor and equipment. DATA This study is based on observational clinical, administrat...

Implications of Global Pricing Policies on Access to Innovative Drugs: the Case of Trastuzumab in Seven Latin American Countries.

OBJECTIVES Differential pricing, based on countries' purchasing power, is recommended by the World Health Organization to secure affordable medicines. However, in developing countries innovative drugs often have similar or even higher prices than in high-income countries. We evaluated the potential implications of trastuzumab global pricing policies in terms of cost-effectiveness (CE), coverage...

Dynamic outcomes based approaches to pricing and reimbursement of innovative medicines

In addition, there is a continuous need for innovative health technologies, such as medicines, that help to substantially reduce morbidity and mortality, and improve quality of life. However, these truly innovative technologies usually come at an extra cost, and – given the requirement for efficiency and sustainability – it is of key importance to establish appropriate methods and procedures fo...

Global Pricing Strategies for Pharmaceutical Product Launches